This discovery uncovers an unexpected, neomorphic insulin-sensitizing effect of FGF1 to treat type 2 diabetes (Suh et al., 2014) and expands the functions of this classically known mitogen. The gene discussed is FGF1; the disease is type 2 diabetes mellitus.